United States Biopsy Devices Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     United States Biopsy 
Devices Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
Acco r d ing  t o  t he  l a t es t  r epo r t  by  I M ARC G r oup ,  t i t l ed  "U n i t e d  S t a t es  B i o psy  
Dev i ces  M ark e t :  I ndus t ry  T r end s ,  Sha re ,  S i ze ,  G r ow t h ,  O p por t un i t y  and  
For ec as t  20 24 - 2 032 , "  t he  U n i t ed  S t a t e s  b iopsy  de v i ces  m a r ke t  s i ze  r each ed  US$  
934 . 3  M i l l i o n  i n  202 3 .
Report The  Un i t ed  S t a t es  b iops y  d ev i ces  m a r ke t  i s  expe r ienc ing  r obus t  g r ow t h  d r i ven  by  
seve r a l  key  t r end s  i n c lud in g  t he  i nc r e as ing  p r e va len ce  o f  cance r ,  wh i ch  has  l ed  t o  a  
h ighe r  dem and  f o r  ea r l y  and  accu r a t e  d iagn os t i c  t oo l s ,  i nc lud ing  b iop sy  de v i ces .  
Highlight and Apar t  f r o m  t h is ,  ong o ing  t e chno log i ca l  adva ncem en t s  in  b iops y  t ec hn ique s ,  su ch  as  
m in im a l l y  i nvas i v e  p r ocedu r es ,  have  im pr oved  pa t i en t  ou t com es  and  r educ ed  
Description r eco ve r y  t im e s ,  m ak ing  t he se  op t i ons  m or e  a t t r ac t i ve  t o  bo t h  hea l t h ca r e  p r ov i de r s  
and  pa t i en t s .  L iqu id  b iops y ,  a  non - invas i ve  a l t e r na t i ve ,  i s  ga in ing  t r ac t io n  due  t o  i t s  
ab i l i t y  t o  de t ec t  ca nce r  t h r ou gh  b loo d  sam p les ,  r e f l ec t i ng  a  sh i f t  t ow ar ds  le ss  
i nvas i ve  d i agnos t i c  m e t h ods .
Reque st  f o r  a  P DF  s ampl e  o f  t h i s  repor t :  
h t t p s : / / www. im ar c g r ou p . com / un i t ed - s t a t es - b iop sy - de v i ces - m ar ke t / r eque s t s am p le
Report Description
U n i t e d  S t a t e s  B i o p s y  D e v i c e s  M a r k e t  T r e n d s :
A d d i t i o n a l l y ,  t h e  r i s e  i n  a w a r e n e s s  c a m p a i g n s  a n d  s c r e e n i n g  p r o g r a m s  b y  g o v e r n m e n t  a n d  h e a l t h c a r e  o r g a n i z a t i o n s  h a s  b o o s t e d  t h e  
n u m b e r  o f  b i o p s i e s  c o n d u c t e d .  T h e  m a r k e t  i s  a l s o  b e n e f i t i n g  f r o m  t h e  i n t e g r a t i o n  o f  a r t i f i c i a l  i n t e l l i g e n c e  ( A I )  a n d  i m a g i n g  
t e c h n o l o g i e s ,  w h i c h  e n h a n c e  t h e  p r e c i s i o n  a n d  e f f i c i e n c y  o f  b i o p s y  p r o c e d u r e s .  F u r t h e r m o r e ,  t h e  a g i n g  p o p u l a t i o n  i n  t h e  U . S .  i s  
c o n t r i b u t i n g  t o  t h e  m a r k e t  g r o w t h ,  a s  o l d e r  i n d i v i d u a l s  a r e  m o r e  l i k e l y  t o  r e q u i r e  b i o p s i e s  f o r  v a r i o u s  c o n d i t i o n s .  T h e  m a r k e t  i s  d r i v e n  
b y  f a c t o r s  b e y o n d  t h e  t r e n d s  i n  c a n c e r  p r e v a l e n c e  a n d  t e c h n o l o g i c a l  a d v a n c e m e n t s .  A  s i g n i f i c a n t  d r i v e r  i s  t h e  r i s i n g  d e m a n d  f o r  
p e r s o n a l i z e d  m e d i c i n e ,  w h e r e  p r e c i s e  d i a g n o s i s  t h r o u g h  b i o p s i e s  e n a b l e s  t a i l o r e d  t r e a t m e n t  p l a n s ,  p a r t i c u l a r l y  i n  o n c o l o g y .  T h i s  t r e n d  
h a s  h e i g h t e n e d  t h e  i m p o r t a n c e  o f  a c c u r a t e  b i o p s y  d e v i c e s  t h a t  c a n  p r o v i d e  d e t a i l e d  m o l e c u l a r  a n d  g e n e t i c  i n f o r m a t i o n ,  f u e l i n g  m a r k e t  
g r o w t h .  A d d i t i o n a l l y ,  t h e  i n c r e a s i n g  a d o p t i o n  o f  o u t p a t i e n t  b i o p s y  p r o c e d u r e s ,  s u p p o r t e d  b y  a d v a n c e m e n t s  i n  p o r t a b l e  a n d  e a s y - t o - u s e  
b i o p s y  d e v i c e s ,  i s  r e d u c i n g  t h e  n e e d  f o r  h o s p i t a l - b a s e d  p r o c e d u r e s ,  m a k i n g  b i o p s i e s  m o r e  a c c e s s i b l e  a n d  c o s t - e f f e c t i v e .  R e g u l a t o r y  
s u p p o r t  a n d  f a s t - t r a c k i n g  o f  n e w  b i o p s y  t e c h n o l o g i e s  b y  t h e  F D A  a l s o  p l a y  a  c r u c i a l  r o l e ,  e n c o u r a g i n g  i n n o v a t i o n  a n d  t h e  q u i c k e r  
i n t r o d u c t i o n  o f  a d v a n c e d  d e v i c e s  i n t o  t h e  m a r k e t .  T h e  m a r k e t  i s  f u r t h e r  s u p p o r t e d  b y  t h e  g r o w i n g  h e a l t h c a r e  i n f r a s t r u c t u r e ,  i n c l u d i n g  
t h e  e x p a n s i o n  o f  d i a g n o s t i c  c e n t e r s  a c r o s s  t h e  U . S . ,  w h i c h  e n h a n c e s  t h e  a v a i l a b i l i t y  a n d  f r e q u e n c y  o f  b i o p s y  p r o c e d u r e s .  M o r e o v e r ,  
r i s i n g  h e a l t h c a r e  e x p e n d i t u r e  a n d  i n c r e a s e d  i n s u r a n c e  c o v e r a g e  f o r  d i a g n o s t i c  p r o c e d u r e s ,  i n c l u d i n g  b i o p s i e s ,  m a k e  t h e s e  p r o c e d u r e s  
m o r e  a f f o r d a b l e  f o r  a  l a r g e r  p o p u l a t i o n .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / u n i t e d - s t a t e s - b i o p s y - d e v i c e s - m a r k e t
Breakup by Procedure Type:
• Surgical  Biopsy
• Needle Biopsy
 
Breakup by Product:
• Biopsy Guidance Systems
• Needle Based Biopsy Guns
Report 
• Biopsy Needles
Segmentation • Biopsy Forceps
• Others
Breakup by Application:
• Breast Biopsy
• Lung Biopsy
• Colorectal  Biopsy
• Prostate Biopsy
• Others
Breakup by Guidance Technique:
• Ultrasound Guided Biopsy
• Stereotact ic Guided Biopsy
Report • MRI Guided Biopsy
Segmentation • Others
Breakup by End User:
• Hospitals and Cl inics
• Academic and Research Insti tutes
• Others
Breakup by Region:
• Northeast
• Midwest
• South
• West
Report 
Segmentation
How has the United States biopsy devices market 
performed so far, and how will it perform in the coming 
years?
What are the drivers, restraints, and opportunities in 
the United States biopsy devices market?
What is the impact of each driver, restraint, and 
Key opportunity on the United States biopsy devices market?
Questions What is the breakup of the market based on the 
procedure type?
Answered in 
Which is the most attractive procedure type in the 
the Report United States biopsy devices market?
What is the breakup of the market based on the 
product?
Which is the most attractive product in the United 
States biopsy devices market?
What is the breakup of the market based on the 
application?
Which is the most attractive application in the United 
States biopsy devices market?
What is the breakup of the market based on the 
guidance technique?
Which is the most attractive guidance technique in the 
Key United States biopsy devices market?
Questions What is the breakup of the market based on the end 
user?
Answered in 
Which is the most attractive end user in the United 
the Report States biopsy devices market?
What is the competitive structure of the United States 
biopsy devices market?
Who are the key players/companies in the United States 
biopsy devices market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     U n i t e d  S t a t e s  B i o p s y  D e v i c e s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o c e d u r e  T y p e
    6 . 1     S u r g i c a l  B i o p s y
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     N e e d l e  B i o p s y
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  P r o d u c t
    7 . 1     B i o p s y  G u i d a n c e  S y s t e m s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     N e e d l e  B a s e d  B i o p s y  G u n s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     B i o p s y  N e e d l e s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     B i o p s y  F o r c e p s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     O t h e r s
Table of         7 . 5 . 1  M a r k e t  T r e n d s        7 . 5 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     B r e a s t  B i o p s y
Contents         8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     L u n g  B i o p s y
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     C o l o r e c t a l  B i o p s y
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     P r o s t a t e  B i o p s y
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
    8 . 5     O t h e r s
        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /u n i t ed - s ta t es -b i o psy -d ev i c es -m a
rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: